Marinomed Biotech AG: Changes in the total number of voting rights and share capital in accordance with Article 135 paragraph 1 BörseG
EQS Comprehensive Voting Rights Notice: Marinemed Biotech AG / publication
Total number of voting rights
Marinemed Biotech AG: Changes in the total number of voting rights and
Capital according to Article 135 paragraph 1 BörseG
31 March 2024 at 10:00 CET/CET
Publication of the total number of voting rights in accordance with Article 135 paragraph 1 BörseG
It is carried by EQS News – a service of EQS Group AG.
The source/publisher is responsible for the content of the message.
Marinemed Biotech AG hereby informs that due to implementation
of convertible bonds with Nice & Green total no
Voting rights at the end of March 2024 total 1,540,530 voting rights
The company's new capital has been increased to €1,540,530.
Change in total number of voting rights since March 27, 2024
effective.
March 31, 2024 CET/Central European Time
German language
Company: Marinemed Biotech AG
Hoffingass 25
2100 Korneuburg
Austria
Internet: www.marinomed.com
End of message EQS News Service
1869389 03/31/2024 CET/Central European Time
ISIN ATMARINOMED6
AXC0005 2024-03-31/10:00
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage is not permitted without the prior express consent of dpa-AFX.
“Total coffee aficionado. Travel buff. Music ninja. Bacon nerd. Beeraholic.”
More Stories
GenAI in everyday work – Top management is moving forward with AI, employees are hesitant » Leadersnet
Foreign Exchange: Euro rises against the dollar
Lufthansa Group: Austrian Airlines, the Boeing 737 MAX and the cargo problem